(Q44335778)

2 December 2017

Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance (English)

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

18 November 2022

0 references

1 reference

1 reference

Anesthesiology and pain medicine

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

18 November 2022

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

18 November 2022

author name string

David E. Kellstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1762818

18 November 2022

David J. Mayer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1762818

18 November 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

full work available at URL

2 December 2017

https://journals.lww.com/10.1016/0304-3959(91)90208-F

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

18 November 2022

1 reference

2 December 2017

47

1 reference

2 December 2017

221-229

1 reference

2 December 2017

2

1 reference

Antagonism of stimulation-produced analgesia by p-CPA, a serotonin synthesis inhibitor.

2 December 2017

1

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

The role of CCK caerulein, and CCK antagonists in nociception

18 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Distribution of cholecystokinin (CCK) in the rat lower brain stem nuclei.

18 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist

18 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system

18 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide

18 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.

18 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

18 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin

18 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

18 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists

18 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Species differences in the localization of 'peripheral' type cholecystokinin receptors in rodent brain.

18 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Binding sites for 125I-cholecystokinin in primate spinal cord are of the CCK-A subclass

18 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the rat

18 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Potency of CR 1409, a new proglumide analog, on cholecystokinin-mediated behaviors and receptor binding.

18 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment

18 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Cholecystokinin and its antagonist lorglumide respectively attenuate and facilitate morphine-induced inhibition of C-fiber evoked discharges of dorsal horn nociceptive neurons.

18 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Proglumide potentiates morphine analgesia for acute postsurgical pain

18 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Two brain cholecystokinin receptors: implications for behavioral actions.

18 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

The ascent of cholecystokinin (CCK) — From gut to brain

18 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329

18 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin

18 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Cholecystokinin Receptors in the Brain: Characterization and Distribution

18 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Localization and opiate receptor binding of enkephalin, CCK and ACTH/β-endorphin in the rat central nervous system

18 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Proglumide prevents and curtails acute tolerance to morphine in rats

18 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand

18 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Do antagonists of pancreatic cholecystokinin receptors interact with central nervous system cholecystokinin receptors?

18 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Pain Relief by Intrathecally Applied Morphine in Man

18 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates

18 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide

18 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide

18 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Intrathecal cholecystokinin interacts with morphine but not substance P in modulating the nociceptive flexion reflex in the rat

18 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

Brain CCK receptors: species differences in regional distribution and selectivity

18 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0304-3959(91)90208-F

18 November 2022

Identifiers

1 reference

2 December 2017

1 reference